AlphaQuest LLC Raises Stock Holdings in Dolby Laboratories $DLB

Key Points

• AlphaQuest LLC increased its holdings in Dolby Laboratories by 89.8% this quarter, acquiring an additional 5,519 shares, bringing its total to 11,667 shares worth approximately $937,000.
• Dolby Laboratories reported a quarterly EPS of $0.78, surpassing analysts' expectations of $0.72, with a revenue of $315.55 million, a 9.2% increase year-over-year.
• Recent insider activity includes significant stock sales by executives, with the EVP selling 15,000 shares and the CEO selling 39,875 shares, contributing to a total of 141,049 shares sold in the last ninety days.

AlphaQuest LLC boosted its stake in shares of Dolby Laboratories (NYSE:DLB - Free Report) by 89.8% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 11,667 shares of the electronics maker's stock after buying an additional 5,519 shares during the period. AlphaQuest LLC's holdings in Dolby Laboratories were worth $937,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in DLB. Palogic Value Management L.P. grew its stake in shares of Dolby Laboratories by 6.4% during the 4th quarter. Palogic Value Management L.P. now owns 3,888 shares of the electronics maker's stock worth $304,000 after acquiring an additional 235 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Dolby Laboratories during the 4th quarter worth approximately $1,872,000. Barclays PLC grew its stake in shares of Dolby Laboratories by 106.6% during the 4th quarter. Barclays PLC now owns 68,646 shares of the electronics maker's stock worth $5,359,000 after acquiring an additional 35,416 shares in the last quarter. Mariner LLC grew its stake in shares of Dolby Laboratories by 31.2% during the 4th quarter. Mariner LLC now owns 9,393 shares of the electronics maker's stock worth $734,000 after acquiring an additional 2,236 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co grew its stake in shares of Dolby Laboratories by 0.5% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 44,954 shares of the electronics maker's stock worth $3,511,000 after acquiring an additional 216 shares in the last quarter. Institutional investors own 58.56% of the company's stock.

Dolby Laboratories Stock Down 0.9%

NYSE DLB traded down $0.65 on Thursday, reaching $72.13. The company had a trading volume of 399,705 shares, compared to its average volume of 431,925. The stock has a market capitalization of $6.91 billion, a P/E ratio of 26.42 and a beta of 0.91. The company's fifty day moving average is $74.27 and its 200 day moving average is $76.44. Dolby Laboratories has a 52-week low of $68.24 and a 52-week high of $89.66.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating the consensus estimate of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The business had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. During the same quarter in the prior year, the business earned $0.71 earnings per share. Dolby Laboratories's revenue for the quarter was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, research analysts expect that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories's payout ratio is presently 48.35%.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, EVP Mark Andrew Sherman sold 15,000 shares of Dolby Laboratories stock in a transaction dated Wednesday, June 4th. The stock was sold at an average price of $75.02, for a total transaction of $1,125,300.00. Following the completion of the transaction, the executive vice president owned 62,397 shares of the company's stock, valued at $4,681,022.94. The trade was a 19.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Yeaman sold 39,875 shares of Dolby Laboratories stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total value of $2,983,447.50. Following the sale, the chief executive officer owned 114,725 shares of the company's stock, valued at approximately $8,583,724.50. This trade represents a 25.79% decrease in their position. The disclosure for this sale can be found here. Insiders sold 148,049 shares of company stock valued at $11,045,581 in the last quarter. 38.39% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Tigress Financial boosted their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a report on Friday, August 15th. Wall Street Zen downgraded Dolby Laboratories from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Barrington Research reaffirmed an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research note on Friday, May 2nd. Finally, Rosenblatt Securities reissued a "buy" rating and set a $95.00 target price on shares of Dolby Laboratories in a research report on Friday, August 1st. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Dolby Laboratories presently has a consensus rating of "Buy" and an average price target of $103.00.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.